Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia

Nicholas J. Short, Elias Jabbour, Trevor Jamison, Shilpa Paul, Branko Cuglievan, David McCall, Amber Gibson, Nitin Jain, Fadi G. Haddad, Lewis F. Nasr, Kayleigh R. Marx, Caitlin Rausch, J. Michael Savoy, Rebecca Garris, Farhad Ravandi, Hagop Kantarjian

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences